Rallybio Corp (RLYB) stock news · rev $858.0K
Rallybio Corp (RLYB) is a biotechnology company listed on US.
This RLYB news page leads with what Rallybio Corp filed — not a scraped headline mill.
No cached 8-K sentence for RLYB yet. We will not pad this page with generic market recap.
Latest reported RLYB revenue for 2025-12-31 was $858.0K. Net income was -$9.0M. Revenue was up 43.0% from 2024-12-31 to 2025-12-31. RLYB currently screens at market cap $13.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RLYB stock page; for the tape open the quote page.
RLYB stock news FAQ
What are RLYB's latest revenue and net income?
Latest cached Rallybio Corp (RLYB) revenue for Dec 31, 2025 was $858.0K. Net income was -$9.0M. Statements: https://lician.com/financials/rlyb
How did RLYB revenue change from the prior cached period?
Cached Rallybio Corp (RLYB) revenue was up 43.0% from $600.0K (Dec 31, 2024) to $858.0K (Dec 31, 2025). Statements: https://lician.com/financials/rlyb
What is RLYB's market cap?
Rallybio Corp (RLYB) market cap is $13.8M on the latest cached fundamentals snapshot.
What kind of company is RLYB?
Rallybio Corp (RLYB) is a biotechnology company listed on US.
Where is RLYB stock news listed?
Cached stock news for Rallybio Corp (RLYB) is listed at https://lician.com/news/rlyb. Filings: https://lician.com/sec/rlyb
Not investment advice.